nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicloxacillin—Renal tubular disorder—Cisplatin—esophageal cancer	0.0724	0.0894	CcSEcCtD
Dicloxacillin—Phlebitis—Carboplatin—esophageal cancer	0.0302	0.0373	CcSEcCtD
Dicloxacillin—Neurotoxicity—Cisplatin—esophageal cancer	0.0271	0.0334	CcSEcCtD
Dicloxacillin—Gastrointestinal tract irritation—Capecitabine—esophageal cancer	0.0217	0.0268	CcSEcCtD
Dicloxacillin—Oesophageal ulcer—Capecitabine—esophageal cancer	0.0212	0.0262	CcSEcCtD
Dicloxacillin—Neurotoxicity—Capecitabine—esophageal cancer	0.02	0.0247	CcSEcCtD
Dicloxacillin—Hepatitis cholestatic—Capecitabine—esophageal cancer	0.0192	0.0237	CcSEcCtD
Dicloxacillin—Reaction gastrointestinal—Methotrexate—esophageal cancer	0.0173	0.0213	CcSEcCtD
Dicloxacillin—SLCO1B1—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.015	0.0793	CbGpPWpGaD
Dicloxacillin—Neurotoxicity—Methotrexate—esophageal cancer	0.0149	0.0184	CcSEcCtD
Dicloxacillin—SLCO1B1—Recycling of bile acids and salts—SLC10A2—esophageal cancer	0.014	0.0737	CbGpPWpGaD
Dicloxacillin—Sneezing—Capecitabine—esophageal cancer	0.014	0.0173	CcSEcCtD
Dicloxacillin—Hepatotoxicity—Cisplatin—esophageal cancer	0.0136	0.0168	CcSEcCtD
Dicloxacillin—Myoclonus—Capecitabine—esophageal cancer	0.0129	0.0159	CcSEcCtD
Dicloxacillin—Nephropathy—Methotrexate—esophageal cancer	0.0121	0.0149	CcSEcCtD
Dicloxacillin—Bone marrow depression—Capecitabine—esophageal cancer	0.0115	0.0142	CcSEcCtD
Dicloxacillin—Ulcer—Cisplatin—esophageal cancer	0.0111	0.0137	CcSEcCtD
Dicloxacillin—Pain—Carboplatin—esophageal cancer	0.0109	0.0135	CcSEcCtD
Dicloxacillin—Wheezing—Cisplatin—esophageal cancer	0.0102	0.0126	CcSEcCtD
Dicloxacillin—Body temperature increased—Carboplatin—esophageal cancer	0.0101	0.0125	CcSEcCtD
Dicloxacillin—Hepatotoxicity—Capecitabine—esophageal cancer	0.01	0.0124	CcSEcCtD
Dicloxacillin—SLCO1B1—Irinotecan Pathway—ABCC2—esophageal cancer	0.00962	0.0506	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.00924	0.0487	CbGpPWpGaD
Dicloxacillin—Phlebitis—Cisplatin—esophageal cancer	0.00885	0.0109	CcSEcCtD
Dicloxacillin—Proteinuria—Capecitabine—esophageal cancer	0.00881	0.0109	CcSEcCtD
Dicloxacillin—Protein urine present—Capecitabine—esophageal cancer	0.00869	0.0107	CcSEcCtD
Dicloxacillin—Bone marrow depression—Methotrexate—esophageal cancer	0.00854	0.0105	CcSEcCtD
Dicloxacillin—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00845	0.0104	CcSEcCtD
Dicloxacillin—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.00823	0.0434	CbGpPWpGaD
Dicloxacillin—Ulcer—Capecitabine—esophageal cancer	0.00819	0.0101	CcSEcCtD
Dicloxacillin—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.00799	0.0421	CbGpPWpGaD
Dicloxacillin—Hepatotoxicity—Methotrexate—esophageal cancer	0.00747	0.00922	CcSEcCtD
Dicloxacillin—SLCO1B1—Bile acid and bile salt metabolism—SLC10A2—esophageal cancer	0.00731	0.0385	CbGpPWpGaD
Dicloxacillin—Oesophagitis—Capecitabine—esophageal cancer	0.00708	0.00874	CcSEcCtD
Dicloxacillin—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00687	0.00848	CcSEcCtD
Dicloxacillin—Proteinuria—Methotrexate—esophageal cancer	0.00656	0.0081	CcSEcCtD
Dicloxacillin—Phlebitis—Capecitabine—esophageal cancer	0.00653	0.00805	CcSEcCtD
Dicloxacillin—Thrombophlebitis—Capecitabine—esophageal cancer	0.00649	0.00802	CcSEcCtD
Dicloxacillin—Protein urine present—Methotrexate—esophageal cancer	0.00647	0.00799	CcSEcCtD
Dicloxacillin—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00646	0.00798	CcSEcCtD
Dicloxacillin—Bone disorder—Methotrexate—esophageal cancer	0.00638	0.00788	CcSEcCtD
Dicloxacillin—Abdominal discomfort—Cisplatin—esophageal cancer	0.00632	0.0078	CcSEcCtD
Dicloxacillin—Pancytopenia—Cisplatin—esophageal cancer	0.00626	0.00773	CcSEcCtD
Dicloxacillin—Haemolytic anaemia—Capecitabine—esophageal cancer	0.00623	0.00769	CcSEcCtD
Dicloxacillin—Ulcer—Methotrexate—esophageal cancer	0.00609	0.00752	CcSEcCtD
Dicloxacillin—Renal impairment—Capecitabine—esophageal cancer	0.00591	0.00729	CcSEcCtD
Dicloxacillin—Renal failure—Cisplatin—esophageal cancer	0.00578	0.00713	CcSEcCtD
Dicloxacillin—Lethargy—Capecitabine—esophageal cancer	0.00574	0.00708	CcSEcCtD
Dicloxacillin—Stomatitis—Cisplatin—esophageal cancer	0.00573	0.00707	CcSEcCtD
Dicloxacillin—Liver function test abnormal—Capecitabine—esophageal cancer	0.00519	0.00641	CcSEcCtD
Dicloxacillin—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00506	0.00625	CcSEcCtD
Dicloxacillin—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00496	0.00612	CcSEcCtD
Dicloxacillin—Thrombophlebitis—Methotrexate—esophageal cancer	0.00483	0.00597	CcSEcCtD
Dicloxacillin—Bronchospasm—Capecitabine—esophageal cancer	0.00478	0.0059	CcSEcCtD
Dicloxacillin—Abdominal discomfort—Capecitabine—esophageal cancer	0.00466	0.00575	CcSEcCtD
Dicloxacillin—CYP3A4—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.00464	0.0244	CbGpPWpGaD
Dicloxacillin—Pancytopenia—Capecitabine—esophageal cancer	0.00461	0.0057	CcSEcCtD
Dicloxacillin—Neutropenia—Capecitabine—esophageal cancer	0.00454	0.00561	CcSEcCtD
Dicloxacillin—Flatulence—Cisplatin—esophageal cancer	0.00453	0.00559	CcSEcCtD
Dicloxacillin—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.00437	0.023	CbGpPWpGaD
Dicloxacillin—Lethargy—Methotrexate—esophageal cancer	0.00427	0.00527	CcSEcCtD
Dicloxacillin—Ill-defined disorder—Cisplatin—esophageal cancer	0.00426	0.00526	CcSEcCtD
Dicloxacillin—Renal failure—Capecitabine—esophageal cancer	0.00426	0.00526	CcSEcCtD
Dicloxacillin—Anaemia—Cisplatin—esophageal cancer	0.00424	0.00524	CcSEcCtD
Dicloxacillin—Stomatitis—Capecitabine—esophageal cancer	0.00422	0.00521	CcSEcCtD
Dicloxacillin—Malaise—Cisplatin—esophageal cancer	0.00414	0.00511	CcSEcCtD
Dicloxacillin—Haematuria—Capecitabine—esophageal cancer	0.00413	0.0051	CcSEcCtD
Dicloxacillin—Leukopenia—Cisplatin—esophageal cancer	0.00411	0.00507	CcSEcCtD
Dicloxacillin—Agranulocytosis—Capecitabine—esophageal cancer	0.00404	0.00499	CcSEcCtD
Dicloxacillin—Convulsion—Cisplatin—esophageal cancer	0.00398	0.00491	CcSEcCtD
Dicloxacillin—Myalgia—Cisplatin—esophageal cancer	0.00391	0.00483	CcSEcCtD
Dicloxacillin—Liver function test abnormal—Methotrexate—esophageal cancer	0.00386	0.00477	CcSEcCtD
Dicloxacillin—Discomfort—Cisplatin—esophageal cancer	0.00386	0.00477	CcSEcCtD
Dicloxacillin—Anaphylactic shock—Cisplatin—esophageal cancer	0.00375	0.00463	CcSEcCtD
Dicloxacillin—Thrombocytopenia—Cisplatin—esophageal cancer	0.00367	0.00453	CcSEcCtD
Dicloxacillin—CYP3A4—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.00367	0.0193	CbGpPWpGaD
Dicloxacillin—Eosinophilia—Methotrexate—esophageal cancer	0.00358	0.00442	CcSEcCtD
Dicloxacillin—Angiopathy—Capecitabine—esophageal cancer	0.00353	0.00436	CcSEcCtD
Dicloxacillin—Hypotension—Cisplatin—esophageal cancer	0.0035	0.00432	CcSEcCtD
Dicloxacillin—Abdominal discomfort—Methotrexate—esophageal cancer	0.00347	0.00428	CcSEcCtD
Dicloxacillin—Pancytopenia—Methotrexate—esophageal cancer	0.00343	0.00424	CcSEcCtD
Dicloxacillin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00341	0.00422	CcSEcCtD
Dicloxacillin—Neutropenia—Methotrexate—esophageal cancer	0.00338	0.00417	CcSEcCtD
Dicloxacillin—Flatulence—Capecitabine—esophageal cancer	0.00334	0.00412	CcSEcCtD
Dicloxacillin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00324	0.00399	CcSEcCtD
Dicloxacillin—CYP3A4—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.00323	0.017	CbGpPWpGaD
Dicloxacillin—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.00322	0.0169	CbGpPWpGaD
Dicloxacillin—Pain—Cisplatin—esophageal cancer	0.00321	0.00396	CcSEcCtD
Dicloxacillin—Renal failure—Methotrexate—esophageal cancer	0.00317	0.00391	CcSEcCtD
Dicloxacillin—Stomatitis—Methotrexate—esophageal cancer	0.00314	0.00388	CcSEcCtD
Dicloxacillin—Ill-defined disorder—Capecitabine—esophageal cancer	0.00314	0.00388	CcSEcCtD
Dicloxacillin—Anaemia—Capecitabine—esophageal cancer	0.00313	0.00386	CcSEcCtD
Dicloxacillin—Feeling abnormal—Cisplatin—esophageal cancer	0.00309	0.00381	CcSEcCtD
Dicloxacillin—Haematuria—Methotrexate—esophageal cancer	0.00307	0.0038	CcSEcCtD
Dicloxacillin—Malaise—Capecitabine—esophageal cancer	0.00305	0.00377	CcSEcCtD
Dicloxacillin—Leukopenia—Capecitabine—esophageal cancer	0.00303	0.00374	CcSEcCtD
Dicloxacillin—Agranulocytosis—Methotrexate—esophageal cancer	0.00301	0.00371	CcSEcCtD
Dicloxacillin—CYP3A4—Irinotecan Pathway—ABCC2—esophageal cancer	0.00297	0.0156	CbGpPWpGaD
Dicloxacillin—Body temperature increased—Cisplatin—esophageal cancer	0.00296	0.00366	CcSEcCtD
Dicloxacillin—Myalgia—Capecitabine—esophageal cancer	0.00288	0.00356	CcSEcCtD
Dicloxacillin—Arthralgia—Capecitabine—esophageal cancer	0.00288	0.00356	CcSEcCtD
Dicloxacillin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.00285	0.015	CbGpPWpGaD
Dicloxacillin—Discomfort—Capecitabine—esophageal cancer	0.00285	0.00352	CcSEcCtD
Dicloxacillin—Confusional state—Capecitabine—esophageal cancer	0.00279	0.00344	CcSEcCtD
Dicloxacillin—Hypersensitivity—Cisplatin—esophageal cancer	0.00276	0.00341	CcSEcCtD
Dicloxacillin—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—esophageal cancer	0.00272	0.0143	CbGpPWpGaD
Dicloxacillin—Shock—Capecitabine—esophageal cancer	0.00272	0.00336	CcSEcCtD
Dicloxacillin—Thrombocytopenia—Capecitabine—esophageal cancer	0.00271	0.00334	CcSEcCtD
Dicloxacillin—Angiopathy—Methotrexate—esophageal cancer	0.00263	0.00324	CcSEcCtD
Dicloxacillin—Hypotension—Capecitabine—esophageal cancer	0.00258	0.00319	CcSEcCtD
Dicloxacillin—Diarrhoea—Cisplatin—esophageal cancer	0.00256	0.00317	CcSEcCtD
Dicloxacillin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.00254	0.0134	CbGpPWpGaD
Dicloxacillin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00252	0.00311	CcSEcCtD
Dicloxacillin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.00246	0.013	CbGpPWpGaD
Dicloxacillin—Dyspepsia—Capecitabine—esophageal cancer	0.00243	0.003	CcSEcCtD
Dicloxacillin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00239	0.00294	CcSEcCtD
Dicloxacillin—Vomiting—Cisplatin—esophageal cancer	0.00238	0.00294	CcSEcCtD
Dicloxacillin—Rash—Cisplatin—esophageal cancer	0.00236	0.00292	CcSEcCtD
Dicloxacillin—Pain—Capecitabine—esophageal cancer	0.00236	0.00292	CcSEcCtD
Dicloxacillin—Dermatitis—Cisplatin—esophageal cancer	0.00236	0.00291	CcSEcCtD
Dicloxacillin—Ill-defined disorder—Methotrexate—esophageal cancer	0.00234	0.00289	CcSEcCtD
Dicloxacillin—Anaemia—Methotrexate—esophageal cancer	0.00233	0.00288	CcSEcCtD
Dicloxacillin—Feeling abnormal—Capecitabine—esophageal cancer	0.00228	0.00281	CcSEcCtD
Dicloxacillin—Malaise—Methotrexate—esophageal cancer	0.00227	0.00281	CcSEcCtD
Dicloxacillin—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.00227	0.0119	CbGpPWpGaD
Dicloxacillin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00226	0.00279	CcSEcCtD
Dicloxacillin—Leukopenia—Methotrexate—esophageal cancer	0.00226	0.00278	CcSEcCtD
Dicloxacillin—Nausea—Cisplatin—esophageal cancer	0.00223	0.00275	CcSEcCtD
Dicloxacillin—Urticaria—Capecitabine—esophageal cancer	0.00219	0.00271	CcSEcCtD
Dicloxacillin—Abdominal pain—Capecitabine—esophageal cancer	0.00218	0.0027	CcSEcCtD
Dicloxacillin—Body temperature increased—Capecitabine—esophageal cancer	0.00218	0.0027	CcSEcCtD
Dicloxacillin—Convulsion—Methotrexate—esophageal cancer	0.00218	0.0027	CcSEcCtD
Dicloxacillin—Myalgia—Methotrexate—esophageal cancer	0.00215	0.00265	CcSEcCtD
Dicloxacillin—Arthralgia—Methotrexate—esophageal cancer	0.00215	0.00265	CcSEcCtD
Dicloxacillin—SLC15A2—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00214	0.0113	CbGpPWpGaD
Dicloxacillin—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.00213	0.0112	CbGpPWpGaD
Dicloxacillin—Discomfort—Methotrexate—esophageal cancer	0.00212	0.00262	CcSEcCtD
Dicloxacillin—Confusional state—Methotrexate—esophageal cancer	0.00207	0.00256	CcSEcCtD
Dicloxacillin—Anaphylactic shock—Methotrexate—esophageal cancer	0.00206	0.00254	CcSEcCtD
Dicloxacillin—Hypersensitivity—Capecitabine—esophageal cancer	0.00204	0.00251	CcSEcCtD
Dicloxacillin—Thrombocytopenia—Methotrexate—esophageal cancer	0.00201	0.00249	CcSEcCtD
Dicloxacillin—SLC15A1—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00198	0.0105	CbGpPWpGaD
Dicloxacillin—SLC15A2—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00196	0.0103	CbGpPWpGaD
Dicloxacillin—Pruritus—Capecitabine—esophageal cancer	0.00195	0.00241	CcSEcCtD
Dicloxacillin—Hypotension—Methotrexate—esophageal cancer	0.00192	0.00237	CcSEcCtD
Dicloxacillin—Diarrhoea—Capecitabine—esophageal cancer	0.00189	0.00233	CcSEcCtD
Dicloxacillin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00187	0.00231	CcSEcCtD
Dicloxacillin—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00182	0.00956	CbGpPWpGaD
Dicloxacillin—Dyspepsia—Methotrexate—esophageal cancer	0.00181	0.00223	CcSEcCtD
Dicloxacillin—CYP3A4—Xenobiotics—CYP2A6—esophageal cancer	0.00178	0.00939	CbGpPWpGaD
Dicloxacillin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00178	0.00219	CcSEcCtD
Dicloxacillin—Pain—Methotrexate—esophageal cancer	0.00176	0.00217	CcSEcCtD
Dicloxacillin—Vomiting—Capecitabine—esophageal cancer	0.00176	0.00217	CcSEcCtD
Dicloxacillin—Rash—Capecitabine—esophageal cancer	0.00174	0.00215	CcSEcCtD
Dicloxacillin—Dermatitis—Capecitabine—esophageal cancer	0.00174	0.00215	CcSEcCtD
Dicloxacillin—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00171	0.00903	CbGpPWpGaD
Dicloxacillin—Feeling abnormal—Methotrexate—esophageal cancer	0.00169	0.00209	CcSEcCtD
Dicloxacillin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00168	0.00208	CcSEcCtD
Dicloxacillin—Nausea—Capecitabine—esophageal cancer	0.00164	0.00203	CcSEcCtD
Dicloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.00164	0.00862	CbGpPWpGaD
Dicloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.00164	0.00862	CbGpPWpGaD
Dicloxacillin—Urticaria—Methotrexate—esophageal cancer	0.00163	0.00202	CcSEcCtD
Dicloxacillin—Abdominal pain—Methotrexate—esophageal cancer	0.00163	0.00201	CcSEcCtD
Dicloxacillin—Body temperature increased—Methotrexate—esophageal cancer	0.00163	0.00201	CcSEcCtD
Dicloxacillin—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.00156	0.00823	CbGpPWpGaD
Dicloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.00153	0.00806	CbGpPWpGaD
Dicloxacillin—Hypersensitivity—Methotrexate—esophageal cancer	0.00152	0.00187	CcSEcCtD
Dicloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.00146	0.00768	CbGpPWpGaD
Dicloxacillin—Pruritus—Methotrexate—esophageal cancer	0.00146	0.0018	CcSEcCtD
Dicloxacillin—Diarrhoea—Methotrexate—esophageal cancer	0.00141	0.00174	CcSEcCtD
Dicloxacillin—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00138	0.00728	CbGpPWpGaD
Dicloxacillin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.00135	0.0071	CbGpPWpGaD
Dicloxacillin—SLCO1B1—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00134	0.00706	CbGpPWpGaD
Dicloxacillin—Vomiting—Methotrexate—esophageal cancer	0.00131	0.00161	CcSEcCtD
Dicloxacillin—Rash—Methotrexate—esophageal cancer	0.0013	0.0016	CcSEcCtD
Dicloxacillin—Dermatitis—Methotrexate—esophageal cancer	0.0013	0.0016	CcSEcCtD
Dicloxacillin—SLCO1B1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00123	0.00646	CbGpPWpGaD
Dicloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.00122	0.00645	CbGpPWpGaD
Dicloxacillin—Nausea—Methotrexate—esophageal cancer	0.00122	0.00151	CcSEcCtD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00122	0.00642	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.00115	0.00604	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00113	0.00596	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.00109	0.00572	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.00106	0.0056	CbGpPWpGaD
Dicloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00104	0.00547	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00104	0.00546	CbGpPWpGaD
Dicloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00103	0.00544	CbGpPWpGaD
Dicloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00103	0.0054	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.00101	0.00531	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000994	0.00523	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000994	0.00523	CbGpPWpGaD
Dicloxacillin—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.000974	0.00513	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000962	0.00507	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000922	0.00486	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000922	0.00486	CbGpPWpGaD
Dicloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000906	0.00477	CbGpPWpGaD
Dicloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000842	0.00444	CbGpPWpGaD
Dicloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000813	0.00428	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000804	0.00423	CbGpPWpGaD
Dicloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000774	0.00408	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000764	0.00402	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000753	0.00397	CbGpPWpGaD
Dicloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00074	0.0039	CbGpPWpGaD
Dicloxacillin—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000738	0.00389	CbGpPWpGaD
Dicloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000731	0.00385	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000718	0.00378	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000699	0.00368	CbGpPWpGaD
Dicloxacillin—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000694	0.00365	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000683	0.0036	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000681	0.00359	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00065	0.00342	CbGpPWpGaD
Dicloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000638	0.00336	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000634	0.00334	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000623	0.00328	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000623	0.00328	CbGpPWpGaD
Dicloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.0006	0.00316	CbGpPWpGaD
Dicloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000597	0.00314	CbGpPWpGaD
Dicloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000589	0.0031	CbGpPWpGaD
Dicloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000569	0.003	CbGpPWpGaD
Dicloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000561	0.00295	CbGpPWpGaD
Dicloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000554	0.00292	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000549	0.00289	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000543	0.00286	CbGpPWpGaD
Dicloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000484	0.00255	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000481	0.00253	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000474	0.00249	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000472	0.00249	CbGpPWpGaD
Dicloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000455	0.0024	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000447	0.00236	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000441	0.00232	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000428	0.00226	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—SLC52A3—esophageal cancer	0.000421	0.00222	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—BLVRB—esophageal cancer	0.000421	0.00222	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000416	0.00219	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000416	0.00219	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.00041	0.00216	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.0004	0.0021	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000386	0.00204	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000376	0.00198	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000371	0.00195	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CA1—esophageal cancer	0.000358	0.00188	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—SLC10A2—esophageal cancer	0.000358	0.00188	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000339	0.00179	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CA2—esophageal cancer	0.000327	0.00172	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000323	0.0017	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.00032	0.00168	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000319	0.00168	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PLCE1—esophageal cancer	0.000304	0.0016	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ADH7—esophageal cancer	0.000304	0.0016	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000302	0.00159	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000301	0.00158	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000267	0.00141	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ADH1B—esophageal cancer	0.000267	0.00141	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000261	0.00137	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000257	0.00135	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—TYMP—esophageal cancer	0.000255	0.00134	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000253	0.00133	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000251	0.00132	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CYP26A1—esophageal cancer	0.000248	0.00131	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000248	0.00131	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ALOX15—esophageal cancer	0.000242	0.00127	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000242	0.00127	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000238	0.00125	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—TPI1—esophageal cancer	0.000231	0.00121	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GSTO1—esophageal cancer	0.000231	0.00121	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ALDOB—esophageal cancer	0.000221	0.00116	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GAPDH—esophageal cancer	0.000213	0.00112	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CRABP1—esophageal cancer	0.000211	0.00111	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GNG7—esophageal cancer	0.000201	0.00106	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ALDH2—esophageal cancer	0.000188	0.00099	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GSTT1—esophageal cancer	0.000179	0.000942	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CYP2A6—esophageal cancer	0.000177	0.000931	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000176	0.000927	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ENO1—esophageal cancer	0.000168	0.000882	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PTGS1—esophageal cancer	0.000168	0.000882	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000167	0.000882	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PSME1—esophageal cancer	0.000165	0.00087	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PSME2—esophageal cancer	0.000165	0.00087	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000144	0.000759	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CYP1B1—esophageal cancer	0.000142	0.00075	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CYP19A1—esophageal cancer	0.000134	0.000705	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.00013	0.000684	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.00013	0.000684	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—HMOX1—esophageal cancer	0.000122	0.000644	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.00012	0.000632	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ABCB1—esophageal cancer	0.000117	0.000618	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CA1—esophageal cancer	0.00011	0.000581	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.00011	0.000581	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CA2—esophageal cancer	0.000101	0.000532	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PLCE1—esophageal cancer	9.39e-05	0.000494	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ADH7—esophageal cancer	9.39e-05	0.000494	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.87e-05	0.000467	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ADH1B—esophageal cancer	8.23e-05	0.000433	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—TYMP—esophageal cancer	7.87e-05	0.000414	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CREBBP—esophageal cancer	7.84e-05	0.000413	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.65e-05	0.000403	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ALOX15—esophageal cancer	7.46e-05	0.000393	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GSTO1—esophageal cancer	7.11e-05	0.000375	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—TPI1—esophageal cancer	7.11e-05	0.000375	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—NOS3—esophageal cancer	7.02e-05	0.00037	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.82e-05	0.000359	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.56e-05	0.000346	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.51e-05	0.000343	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PTGS2—esophageal cancer	6.42e-05	0.000338	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GNG7—esophageal cancer	6.19e-05	0.000326	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.8e-05	0.000305	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.52e-05	0.00029	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.45e-05	0.000287	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—EP300—esophageal cancer	5.34e-05	0.000281	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ENO1—esophageal cancer	5.17e-05	0.000272	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PTGS1—esophageal cancer	5.17e-05	0.000272	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PSME2—esophageal cancer	5.09e-05	0.000268	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PSME1—esophageal cancer	5.09e-05	0.000268	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.39e-05	0.000231	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.13e-05	0.000218	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	3.95e-05	0.000208	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.77e-05	0.000199	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.62e-05	0.000191	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.42e-05	0.000127	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—NOS3—esophageal cancer	2.17e-05	0.000114	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.98e-05	0.000104	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—EP300—esophageal cancer	1.65e-05	8.67e-05	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.22e-05	6.42e-05	CbGpPWpGaD
